BCAL Diagnostics Ltd
ASX:BDX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BCAL Diagnostics Ltd
ASX:BDX
|
AU |
|
M
|
Munic SA
PAR:ALMUN
|
FR |
|
A
|
Alaska Air Group Inc
SWB:ALK
|
US |
|
A
|
Alstom SA
XMUN:AOMD
|
FR |
|
T
|
TRC Synergy Bhd
KLSE:TRC
|
MY |
|
T
|
TS Corp
KRX:001790
|
KR |
|
H
|
Healius Ltd
SWB:PGZ
|
AU |
|
Aegis Brands Inc
TSX:AEG
|
CA |
|
C
|
ClearVue Technologies Ltd
ASX:CPV
|
AU |
|
S
|
Salesforce Inc
SWB:FOO
|
US |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
CN |
|
Verallia SA
F:1VRA
|
FR |
|
Libas Consumer Products Ltd
NSE:LIBAS
|
IN |
Bankruptcy Probability
BCAL Diagnostics Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
BCAL Diagnostics Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
BCAL Diagnostics Ltd
ASX:BDX
|
25.8m AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
464.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
203.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
181.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
83.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
57.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
50.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
43.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
BCAL Diagnostics Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, BCAL Diagnostics Ltd has total debt of 3m AUD. This includes both short-term (0 AUD) and long-term (3m AUD) debt.
You can find a full breakdown on its Balance Sheet.